Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of budesonide, montelukast and their combination in allergic rhinitis
IRCT20171030037093N41Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide and montelukast in allergic rhinitis (AR) (3 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2020; status: completed.
02
Drugs
budesonidemontelukast
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20171030037093N41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N41.